Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,278 | 9,405 | 10,845 | 16,824 | 23,550 |
| TOTAL | $5,194 | $11,606 | $13,731 | $18,957 | $26,273 |
| Non-Current Assets | |||||
| PPE Net | 159 | 190 | 221 | 240 | 272 |
| Intangibles | 11,148 | 11,148 | 11,148 | 11,148 | 11,148 |
| Other Non-Current Assets | 424 | 450 | 475 | 500 | 524 |
| TOTAL | $11,731 | $11,788 | $11,844 | $11,888 | $11,944 |
| Total Assets | $16,925 | $23,394 | $25,575 | $30,845 | $38,217 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,359 | 5,593 | 5,746 | 5,408 | 6,815 |
| TOTAL | $5,359 | $5,593 | $5,746 | $5,408 | $6,815 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 358 | 10,322 | 2,124 | 3,850 | 5,329 |
| TOTAL | $358 | $10,322 | $2,124 | $3,850 | $5,329 |
| Total Liabilities | $5,717 | $15,915 | $7,870 | $9,258 | $12,144 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 560 | 120 | 102 | 92 | 6 |
| Common Shares | N/A | 3 | 3 | 2 | 33 |
| Retained earnings | -172,444 | -151,485 | -140,893 | -136,574 | -131,604 |
| Other shareholders' equity | -41 | 4 | -10 | -18 | -9 |
| TOTAL | $11,208 | $7,479 | $17,705 | $21,587 | $26,073 |
| Total Liabilities And Equity | $16,925 | $23,394 | $25,575 | $30,845 | $38,217 |